Publication | Open Access

Efficacy and Safety of Donepezil in Patients with Schizophrenia or Schizoaffective Disorder: Significant Placebo/Practice Effects in a 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial

Significant Placebo/practice EffectsPsychiatryPsychotic DisorderPharmacologyPsychopharmacologySchizophreniaPlacebo-controlled TrialSocial SciencesPharmacotherapyMedicineSchizoaffective DisorderPsychopathology